Enliven Therapeutics ELVN
NASDAQ ELVN
$46.97 +0.76 (+1.64%)
At close: Oct 2, 2026 · 4:00 PM EDT

Enliven Therapeutics (ELVN) Return on Assets [ROA] (2020 - 2026)

Updated

Enliven Therapeutics (ELVN) posted Return on Assets [ROA] of -18.10% for Q2 2026, up 10.24 percentage points from -28.33% a year earlier and up 6.51 percentage points from the prior quarter.

Analysis

Enliven Therapeutics (ELVN) Return on Assets [ROA] (2020 - 2026) Analysis & Trends

For FY2025, Enliven Therapeutics' Return on Assets [ROA] came in at -29.84%, up 5.22 percentage points from FY2024.

  • Annual Return on Assets [ROA] shows a five-year change of +37.34 percentage points (FY2020 to FY2025).
  • In prior years, Enliven Therapeutics' Return on Assets [ROA] was -35.07% in FY2024 (+11.97 pp), -47.04% in FY2023 (-48.72 pp), 1.68% in FY2022 (+57.39 pp) and -55.70% in FY2021 (+11.47 pp).
  • The Q2 2026 figure stands as the highest quarterly Return on Assets [ROA] in data going back to Q1 2020.
  • On a year-over-year basis, Return on Assets [ROA] has increased in each of the last five quarters, with an average year-over-year change of +3.16 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Assets [ROA] in the past five years was Q3 2023, with a gain of 44.19 percentage points; the weakest was Q3 2021, with a drop of 18.63 percentage points.
  • According to Business Quant data, Return on Assets [ROA] for the three prior quarters was -24.61% (Q1 2026), -24.75% (Q4 2025) and -22.57% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 20.64%
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 10.47%
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 4.65%
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 2.45%
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 28.37%
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 9.10%
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 9.29%
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn -6.13%
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 2.14%
10 Enliven Therapeutics 3.38 Bn 3.38 Bn - -18.10%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -18.10%
Mar 31, 2026 -24.61%
Dec 31, 2025 -24.75%
Sep 30, 2025 -22.57%
Jun 30, 2025 -28.33%
Mar 31, 2025 -35.17%
Dec 31, 2024 -33.20%
Sep 30, 2024 -31.82%
Jun 30, 2024 -29.20%
Mar 31, 2024 -30.29%
Dec 31, 2023 -30.60%
Sep 30, 2023 -25.23%
Jun 30, 2023 -19.50%
Mar 31, 2023 -24.10%
Dec 31, 2022 -54.48%
Sep 30, 2022 -69.42%
Jun 30, 2022 -62.47%
Mar 31, 2022 -56.88%
Dec 31, 2021 -51.27%
Sep 30, 2021 -54.22%
API Access

Enliven Therapeutics Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=ELVN&period=max&api_key=YOUR_API_KEY